Search

Your search keyword '"Membranous Nephropathy"' showing total 6,684 results

Search Constraints

Start Over You searched for: Descriptor "Membranous Nephropathy" Remove constraint Descriptor: "Membranous Nephropathy"
6,684 results on '"Membranous Nephropathy"'

Search Results

101. Pharmacological targets of SGLT2 inhibitors on IgA nephropathy and membranous nephropathy: a mendelian randomization study.

102. Ten tips on immunosuppression in primary membranous nephropathy.

103. Combined evaluation of glomerular phospholipase A2 receptor and immunoglobulin G subclass in membranous nephropathy.

104. The Prevalence, Characteristics, and Putative Mechanisms of Dual Antigen-Positive Membranous Nephropathy: The Underestimated Condition.

105. Rituximab Treatment Outcomes in Relapsed Primary Membranous Nephropathy: A Single-center Retrospective Study.

106. Meta-analysis of the effects of CYP3A5*3 gene polymorphisms on tacrolimus blood concentration and effectiveness in Chinese patients with membranous nephropathy.

107. Genetic association between membranous nephropathy and malignancies: a two-sample Mendelian randomisation study.

108. The causal association of specific gut microbiota on the risk of membranous nephropathy: a Mendelian randomization study.

109. Therapeutic plasmapheresis in idiopathic membranous nephropathy anti‐PLA2R‐related: A case series.

110. A new notable compression source of left renal vein entrapment: right renal artery.

111. Application of CD38 monoclonal antibody in kidney disease.

112. Nefropatía membranosa con patrón “Lupus-like” en paciente con VIH y enfermedad de Castleman.

113. Podocyte-specific proteins in urinary extracellular vesicles of patients with IgA nephropathy: Vasorin and ceruloplasmin.

114. IMPORTANCIA DIAGNÓSTICA DEL C4d EN LA NEFROPATÍA MEMBRANOSA.

115. Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis.

116. Membranous Nephropathy as a Paraneoplastic Syndrome in Cancer of Unknown Primary.

119. Animal models of membranous nephropathy: more choices and higher similarity

120. Complement Receptor 1 Enhancement in Recurrent Membranous Nephropathy Following Kidney Transplantation: A Case Report

121. Obinutuzumab in Refractory Membranous Nephropathy: A Case Series

122. Clinicopathologic features of non-lupus membranous nephropathy in a pediatric population

123. IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report

124. Giant retinal pigment epithelium tears with membranous nephropathy: a case report and literature review

125. Glomerulonephritis after Alemtuzumab Treatment for Multiple Sclerosis: A Report of Two Cases

126. Targeted therapy in glomerular diseases

127. Diagnostic value of renal biopsy in anti-phospholipase A2 receptor antibody-positive patients with proteinuria in China

128. Antibodies Against Anti-Oxidant Enzymes in Autoimmune Glomerulonephritis and in Antibody-Mediated Graft Rejection

129. Case Report: Mercury-induced renal autoimmunity – An insight into its pathogenesis [version 1; peer review: awaiting peer review]

132. Development of a nomogram for membranous nephropathy prediction in patients with primary Sjögren's syndrome: a 6-year retrospective study.

133. Giant retinal pigment epithelium tears with membranous nephropathy: a case report and literature review.

134. Membranous nephropathy—diagnosis and identification of target antigens.

135. Using the therapeutic properties of wind herbs to treat membranous nephropathy.

136. Effects of GDF-15 Level in Patients with Membranous Nephropathy.

137. Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases.

138. An Updated Review of Membranous Nephropathy.

139. Practice patterns of rituximab for primary membranous nephropathy 2021 in Japan: a web-based survey of board-certified nephrologists.

140. Membranous nephropathy treatment standard.

141. A Case of Castleman's Disease with a Marked Infiltration of IgG4-Positive Cells in the Renal Interstitium.

142. Glomérulonéphrite extramembraneuse : outils diagnostiques, pronostiques et d'aide à la décision thérapeutique.

143. Diagnostic value of renal biopsy in anti-phospholipase A2 receptor antibody-positive patients with proteinuria in China.

144. Utility of C4d Immunohistochemistry as an Adjunct Stain in Diagnostic Renal Pathology of Glomerular Diseases.

145. Targeted therapy in glomerular diseases.

146. Role of metabolomic profile as a potential marker to discriminate membranous nephropathy from IgA nephropathy.

147. Colquhounia root tablet in the treatment of idiopathic membranous nephropathy with subnephrotic proteinuria.

148. Complement Activation in Nephrotic Glomerular Diseases.

149. miR‐664a‐5p promotes experimental membranous nephropathy progression through HIPK2/Calpain1/GSα‐mediated autophagy inhibition.

150. Antibrush Border Antibody Disease: A Case Series

Catalog

Books, media, physical & digital resources